Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

NCT01224015 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
684
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergan